Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06300424
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-03-03
Brief Title:
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
Sponsor:
Guangdong Provincial Peoples Hospital
Organization:
Guangdong Provincial Peoples Hospital
Organization Data
Organization:
Guangdong Provincial Peoples Hospital
Class:
OTHER
Study ID:
KY2024-162
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Guangdong Provincial Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Wen-zhao ZHONG
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Guangdong Provincial Peoples Hospital
Old Name:
None
Old Organization:
None